NCT07332312 A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Indian and Alaska Native Cancer Patients Living in Rural California
| NCT ID | NCT07332312 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Southern California |
| Condition | Hematopoietic and Lymphatic System Neoplasm |
| Study Type | INTERVENTIONAL |
| Enrollment | 71 participants |
| Start Date | 2026-04-17 |
| Primary Completion | 2027-11-13 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 71 participants in total. It began in 2026-04-17 with a primary completion date of 2027-11-13.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial develops and tests whether a culturally informed patient navigation program, Community-Focused Patient Navigation (CFPN), works to reduce delays between diagnosis and treatment in American Indian and Alaska Native (AIAN) cancer patients living in rural California. AIAN communities face some of the most severe cancer disparities in the United States, including higher death rates, later-stage diagnoses, and limited access to timely, culturally responsive care. This may be due to barriers such as rural isolation, divided referral systems, or a lack of trust in mainstream healthcare systems. Patient navigation is a care delivery model designed to guide a patient through the healthcare system and address the barriers that prevent patients from accessing timely and effective care. The CFPN program is culturally tailored and designed with AIAN communities in mind. The program provides the patient with a treatment plan based on the patient's unique needs, goals, and barriers. This may be an effective way to reduce delays between diagnosis and treatment in AIAN cancer patients living in rural California.
Eligibility Criteria
Inclusion Criteria: * CAB: Self-identify as AIAN or have experience working with the AIAN community * CAB: Are 18 years or older * CAB: Live within Toiyabe Indian Health Program (TIHP) catchment area(s) * CAB: Are either a cancer patient/survivor/caregiver and/or a family member of an individual(s) affected by cancer, OR a Board member (ex: Tribal Health Board or Elders Board) * FOCUS GROUP: Self-identify as AIAN or a family member of an AIAN individual affected by cancer * FOCUS GROUP: Are 18 years or older * FOCUS GROUP: Live within TIHP catchment area(s) * FOCUS GROUP: Are either a cancer patient/survivor/caregiver and/or a family member of an individual(s) affected by cancer, OR a Board member (ex: Tribal Health Board or Elders Board) * KII: Be a TIHP healthcare staff member * KII: Be 18 years or older * KII: Work with AIAN cancer patients in TIHP catchment area * CFPN PROGRAM IMPLEMENTATION: Have any type of cancer, are in any treatment stage along the cancer continuum * CFPN PROGRAM IMPLEMENTATION: Self-identify as AIAN or be a TIHP patient * CFPN PROGRAM IMPLEMENTATION: Live in the TIHP service area * CFPN PROGRAM IMPLEMENTATION: Receive cancer-related services from TIHP Exclusion Criteria: * FOCUS GROUP: Individual with no experience with cancer either as a patient or know someone who is/was a cancer patient at TIHP * CFPN PROGRAM IMPLEMENTATION: Not a TIHP patient * CFPN PROGRAM IMPLEMENTATION: Does not currently have cancer or has not previously had cancer
Contact & Investigator
Claradina Soto
PRINCIPAL INVESTIGATOR
University of Southern California
Frequently Asked Questions
Who can join the NCT07332312 clinical trial?
This trial is open to participants of all sexes, studying Hematopoietic and Lymphatic System Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07332312 currently recruiting?
Yes, NCT07332312 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Southern California to inquire about joining.
Where is the NCT07332312 trial being conducted?
This trial is being conducted at Bishop, United States, Los Angeles, United States.
Who is sponsoring the NCT07332312 clinical trial?
NCT07332312 is sponsored by University of Southern California. The principal investigator is Claradina Soto at University of Southern California. The trial plans to enroll 71 participants.